Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001193125-25-248847
Filing Date
2025-10-23
Accepted
2025-10-23 16:37:58
Documents
3

Document Format Files

Seq Description Document Type Size
1 424B5 d31946d424b5.htm 424B5 429452
2 GRAPHIC g31946g01a29.jpg GRAPHIC 51241
3 GRAPHIC g31946g04g04.jpg GRAPHIC 53232
  Complete submission text file 0001193125-25-248847.txt   553469
Mailing Address 12645 MEMORIAL DR., SUITE F1 #305 HOUSTON TX 77024
Business Address 12645 MEMORIAL DR., SUITE F1 #305 HOUSTON TX 77024 650.739.3939
Coya Therapeutics, Inc. (Filer) CIK: 0001835022 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-289511 | Film No.: 251413558
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)